Sachem Ventures
1
1M
1
1
- Stages of investment
- Areas of investment
Summary
The main office of represented VC is situated in the New Haven. The fund was located in North America if to be more exact in United States.
The important activity for fund was in 2004. The increased amount of exits for fund were in 2012. Deals in the range of 1 - 5 millions dollars are the general things for fund. The fund is constantly included in less than 2 investment rounds annually.
The typical case for the fund is to invest in rounds with 2 participants. The meaningful sponsors for the fund in investment in the same round are Navigator Technology Ventures. In the next rounds fund is usually obtained by Maven Capital Partners, Commons Capital, Brook Venture Partners.
Among the most popular fund investment industries, there are Alternative Medicine, Biotechnology. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight HistoRx.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Exits
- 1
- Investments by industry
- Therapeutics (1)
- Biotechnology (1)
- Alternative Medicine (1)
- Investments by region
-
- United States (1)
- Peak activity year
- 2004
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 17
- Group Appearance index
- 1.00
- Avg. company exit year
- 8
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
HistoRx | 14 Sep 2004 | Biotechnology, Therapeutics, Alternative Medicine | Early Stage Venture | 1M | United States, Connecticut, New Haven |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.